Literature DB >> 28697983

Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles.

Jan W Balder1, Jeroen K de Vries2, Ilja M Nolte3, Peter J Lansberg4, Jan A Kuivenhoven5, Pieter W Kamphuisen6.   

Abstract

BACKGROUND: Lipids and lipoproteins are recognized as the most important modifiable risk factors for cardiovascular disease. Although reference values for the major lipoproteins, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, and triglycerides, have been collected in numerous studies and cohorts, complete contemporary percentile-based reference values are underreported.
OBJECTIVE: We set out to provide such reference lipid data using a large contemporary population-based cohort study. STUDY DESIGN AND
SETTING: Lifelines is a cross-sectional population-based Dutch cohort study. We analyzed 133,540 adult fasting participants without cardiovascular disease and without lipid-lowering drug use. Lipid levels were directly measured and selected percentiles of all lipid parameters were calculated. Friedewald LDL-C estimation was calculated as well.
RESULTS: From 20 till 49 years of age, men were found to exhibit a steep 64% increase of LDL-C (median +54 mg/dL), while triglyceride levels increased almost two-fold. In women, LDL-C levels did not change from 18 till 35 years, followed by a steep 42% increase till 59 years (median +42 mg/dL). In contrast to men, triglycerides were stable in ageing women. Overall, Friedewald LDL-C levels are lower compared with the direct measurement, especially with increasing triglyceride levels.
CONCLUSIONS: This observational study highlights striking gender- and age-related differences in plasma lipid profiles. The given reference ranges of plasma lipids can assist in early identification of individuals with hypocholesterolemia and hypercholesterolemia, especially familial hypercholesterolemia. These reference ranges are available for physicians and patients at www.my-cholesterol.care/.
Copyright © 2017 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Cardiovascular risk factors; Cholesterol; Familial hypercholesterolemia; Lipid levels; Population study; Primary prevention; Reference values

Mesh:

Substances:

Year:  2017        PMID: 28697983     DOI: 10.1016/j.jacl.2017.05.007

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  21 in total

1.  The long-term effect of mTOR inhibition on lipid and glucose metabolism in tuberous sclerosis complex: data from the Dutch TSC registry.

Authors:  Femke V M Mulder; Evelien F H I Peeters; Jan Westerink; Fried J T Zwartkruis; Wendela L de Ranitz-Greven
Journal:  Orphanet J Rare Dis       Date:  2022-07-08       Impact factor: 4.303

2.  Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders.

Authors:  Elina J Reponen; Ingrid Dieset; Martin Tesli; Ragni H Mørch; Monica Aas; Trude S J Vedal; Elisabeth Haug; Ole Kristian Drange; Nils Eiel Steen; Sigrun Hope; Attila Szabo; Sherif M Gohar; Kirsten Wedervang-Resell; Srdjan Djurovic; Ingrid Melle; Pål Aukrust; Ole A Andreassen; Thor Ueland
Journal:  Front Psychiatry       Date:  2020-07-10       Impact factor: 4.157

3.  Free Fatty Acid is a Promising Biomarker in Triage Screening for Patients with Colorectal Cancer: A Case-Control Study.

Authors:  Bin Zhu; Junrong Zhang; Qingzhu Zheng; Binhua Dong; Meihua Wang; Jin Liu; Yingping Cao
Journal:  Cancer Manag Res       Date:  2021-05-10       Impact factor: 3.989

4.  The cost-effectiveness of a two-step blood pressure screening programme in a dental health-care setting.

Authors:  Helen Andersson; Mikael Svensson; Håkan Bergh
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

5.  Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol.

Authors:  Istvan Reiber; Laszlo Mark; Gyorgy Paragh; Peter P Toth
Journal:  Arch Med Sci       Date:  2020-08-03       Impact factor: 3.318

6.  Metabolic syndrome detection with biomarkers in childhood cancer survivors.

Authors:  V G Pluimakers; M van Waas; C W N Looman; M P de Maat; R de Jonge; P Delhanty; M Huisman; F U S Mattace-Raso; M M van den Heuvel-Eibrink; S J C M M Neggers
Journal:  Endocr Connect       Date:  2020-07       Impact factor: 3.335

7.  MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines.

Authors:  Bo Burla; Makoto Arita; Masanori Arita; Anne K Bendt; Amaury Cazenave-Gassiot; Edward A Dennis; Kim Ekroos; Xianlin Han; Kazutaka Ikeda; Gerhard Liebisch; Michelle K Lin; Tze Ping Loh; Peter J Meikle; Matej Orešič; Oswald Quehenberger; Andrej Shevchenko; Federico Torta; Michael J O Wakelam; Craig E Wheelock; Markus R Wenk
Journal:  J Lipid Res       Date:  2018-08-16       Impact factor: 5.922

8.  Exploration of Blood Lipoprotein and Lipid Fraction Profiles in Healthy Subjects through Integrated Univariate, Multivariate, and Network Analysis Reveals Association of Lipase Activity and Cholesterol Esterification with Sex and Age.

Authors:  Yasmijn Balder; Alessia Vignoli; Leonardo Tenori; Claudio Luchinat; Edoardo Saccenti
Journal:  Metabolites       Date:  2021-05-18

9.  Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative.

Authors:  Rahmat Sediq; Jurjen van der Schans; Aafje Dotinga; Rolinde A Alingh; Bob Wilffert; Jens Hj Bos; Catharina Cm Schuiling-Veninga; Eelko Hak
Journal:  Clin Epidemiol       Date:  2018-08-16       Impact factor: 4.790

Review 10.  LDL-Cholesterol Lowering of Plant Sterols and Stanols-Which Factors Influence Their Efficacy?

Authors:  Elke A Trautwein; Mario A Vermeer; Harry Hiemstra; Rouyanne T Ras
Journal:  Nutrients       Date:  2018-09-07       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.